Altimmune Inc (ALT)
7.04
-0.48
(-6.38%)
USD |
NASDAQ |
Apr 17, 16:00
7.09
+0.05
(+0.71%)
After-Hours: 07:09
Altimmune Cash from Investing (Quarterly): -7.959M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.959M |
| September 30, 2023 | 4.402M |
| June 30, 2023 | 3.987M |
| March 31, 2023 | 13.30M |
| December 31, 2022 | 0.981M |
| September 30, 2022 | -25.40M |
| June 30, 2022 | -48.97M |
| March 31, 2022 | -0.009M |
| December 31, 2021 | 24.87M |
| September 30, 2021 | 18.41M |
| June 30, 2021 | 25.08M |
| March 31, 2021 | 19.16M |
| December 31, 2020 | -37.00M |
| September 30, 2020 | -47.89M |
| June 30, 2020 | 6.098M |
| March 31, 2020 | 6.563M |
| December 31, 2019 | -0.0527M |
| September 30, 2019 | -28.22M |
| June 30, 2019 | -0.0129M |
| March 31, 2019 | -0.0042M |
| December 31, 2018 | -0.0081M |
| September 30, 2018 | -0.1539M |
| June 30, 2018 | -0.1717M |
| March 31, 2018 | -0.6675M |
| December 31, 2017 | -0.0287M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0154M |
| June 30, 2017 | 13.63M |
| March 31, 2017 | 0.1431M |
| December 31, 2016 | -0.0412M |
| September 30, 2016 | -0.1194M |
| June 30, 2016 | -0.0597M |
| March 31, 2016 | -0.0001M |
| December 31, 2015 | -0.0182M |
| September 30, 2015 | -0.012M |
| June 30, 2015 | -0.0209M |
| March 31, 2015 | -0.0278M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.013M |
| June 30, 2014 | -0.0422M |
| March 31, 2014 | -0.029M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.0105M |
| June 30, 2013 | -0.0451M |
| March 31, 2013 | -0.0255M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.0674M |
| December 31, 2011 | 1.759M |
| September 30, 2011 | -0.0411M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-48.97M
Minimum
Jun 2022
25.08M
Maximum
Jun 2021
-3.824M
Average
0.981M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -2.924B |
| Amgen Inc | -27.09B |
| Viking Therapeutics Inc | 35.73M |
| Precision BioSciences Inc | 0.042M |
| Terns Pharmaceuticals Inc | 47.23M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.53M |
| Cash from Financing (Quarterly) | 72.75M |
| Free Cash Flow | -75.86M |
| Free Cash Flow Per Share (Quarterly) | -0.2826 |
| Free Cash Flow to Equity (Quarterly) | -16.53M |
| Free Cash Flow to Firm (Quarterly) | -16.53M |
| Free Cash Flow Yield | -20.24% |